173 related articles for article (PubMed ID: 8852167)
1. Gaucher disease: an overview of clinical characteristics and therapy.
Kingma W
J Intraven Nurs; 1996; 19(2):79-82. PubMed ID: 8852167
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment of Gaucher disease in Croatia].
Mrsić M
Lijec Vjesn; 2007 May; 129 Suppl 3():38-42. PubMed ID: 18959062
[TBL] [Abstract][Full Text] [Related]
3. [Gaucher disease: clinical, genetic and therapeutic aspects].
Germain DP
Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
[TBL] [Abstract][Full Text] [Related]
4. Gaucher disease, enzyme replacement therapy, and the Patient Assistance Program.
Goldwater RS
J Intraven Nurs; 1996; 19(2):83-8. PubMed ID: 8852168
[TBL] [Abstract][Full Text] [Related]
5. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
Pastores GM
Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
[TBL] [Abstract][Full Text] [Related]
6. Gaucher's disease: a review for the internist and hepatologist.
Niederau C; Häussinger D
Hepatogastroenterology; 2000; 47(34):984-97. PubMed ID: 11020862
[TBL] [Abstract][Full Text] [Related]
7. Individualization of long-term enzyme replacement therapy for Gaucher disease.
Andersson HC; Charrow J; Kaplan P; Mistry P; Pastores GM; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ;
Genet Med; 2005 Feb; 7(2):105-10. PubMed ID: 15714077
[TBL] [Abstract][Full Text] [Related]
8. [French results of enzyme replacement therapy in Gaucher's disease].
Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
[TBL] [Abstract][Full Text] [Related]
9. Gaucher disease: from fundamental research to effective therapeutic interventions.
de Fost M; Aerts JM; Hollak CE
Neth J Med; 2003 Jan; 61(1):3-8. PubMed ID: 12688562
[TBL] [Abstract][Full Text] [Related]
10. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
Chang HH; Asano N; Ishii S; Ichikawa Y; Fan JQ
FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
[TBL] [Abstract][Full Text] [Related]
11. Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone.
Mikosch P
Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):665-81. PubMed ID: 22142746
[TBL] [Abstract][Full Text] [Related]
12. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
Fabrega S; Lehn P
J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
14. The role of neurogenetics in Gaucher disease.
Brady RO; Barton NW; Grabowski GA
Arch Neurol; 1993 Nov; 50(11):1212-24. PubMed ID: 8215980
[TBL] [Abstract][Full Text] [Related]
15. Orthopaedic manifestations of Gaucher disease.
Lutsky KF; Tejwani NC
Bull NYU Hosp Jt Dis; 2007; 65(1):37-42. PubMed ID: 17539760
[TBL] [Abstract][Full Text] [Related]
16. [Gaucher disease: diagnosis and treatment].
Fumić K; Stavljenić-Rukavina A; Mrsić M; Potocki K
Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799
[TBL] [Abstract][Full Text] [Related]
17. [From gene to disease; Gaucher disease].
Hollak CE; Boot RG; Poorthuis BJ; Aerts JM
Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076
[TBL] [Abstract][Full Text] [Related]
18. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.
Grabowski GA; Barton NW; Pastores G; Dambrosia JM; Banerjee TK; McKee MA; Parker C; Schiffmann R; Hill SC; Brady RO
Ann Intern Med; 1995 Jan; 122(1):33-9. PubMed ID: 7985893
[TBL] [Abstract][Full Text] [Related]
19. [Gaucher's disease: pathogenesis, diagnosis and therapy].
Pregun I; Tulassay Z
Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
[TBL] [Abstract][Full Text] [Related]
20. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.
Di Rocco M; Giona F; Carubbi F; Linari S; Minichilli F; Brady RO; Mariani G; Cappellini MD
Haematologica; 2008 Aug; 93(8):1211-8. PubMed ID: 18603565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
